Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate in STEAMI with Hyperfibrinogenemia
NCT02291796Phase 4Completed
- Sponsor
- Instituto Mexicano del Seguro Social
- Start
- Jan 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of bezafibrate in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by Instituto Mexicano del Seguro Social. Primary endpoints: Fibrinogen levels at 3 months and Inflammatory response at 1 month. Started Jan 2011; status: completed.
02
Drugs
bezafibrate
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02291796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291796.